Chester Andrzejewski to Blood Safety
This is a "connection" page, showing publications Chester Andrzejewski has written about Blood Safety.
Connection Strength
1.779
-
Edens C, Haass KA, Cumming M, Osinski A, O'Hearn L, Passanisi K, Eaton L, Visintainer P, Savinkina A, Kuehnert MJ, Basavaraju SV, Andrzejewski C. Evaluation of the National Healthcare Safety Network Hemovigilance Module for transfusion-related adverse reactions in the United States. Transfusion. 2019 02; 59(2):524-533.
Score: 0.615
-
Cumming M, Osinski A, O'Hearn L, Waksmonski P, Herman M, Gordon D, Griffiths E, Knox K, McHale E, Quillen K, Rios J, Pisciotto P, Uhl L, DeMaria A, Andrzejewski C. Hemovigilance in Massachusetts and the adoption of statewide hospital blood bank reporting using the National Healthcare Safety Network. Transfusion. 2017 02; 57(2):478-483.
Score: 0.533
-
Iannone A, Cumming M, Osinski A, Brandeburg C, Schultz J, Slider A, Rodrigue B, O'Hearn L, Herman M, McHale E, Rios J, Uhl L, Andrzejewski C, DeMaria A. How do we use the National Healthcare Safety Network for Hemovigilance in Massachusetts? Transfusion. 2024 02; 64(2):200-209.
Score: 0.219
-
Rajbhandary S, Andrzejewski C, Fridey J, Stotler B, Tsang HC, Hindawi S, Reddy O, Medina MC, Razatos A, Narayan S, Fung M. Incorporating the entity of under-transfusion into hemovigilance monitoring: Documenting cases due to lack of inventory. Transfusion. 2022 03; 62(3):540-545.
Score: 0.192
-
Mowla SJ, Kracalik IT, Sapiano MRP, O'Hearn L, Andrzejewski C, Basavaraju SV. A Comparison of Transfusion-Related Adverse Reactions Among Apheresis Platelets, Whole Blood-Derived Platelets, and Platelets Subjected to Pathogen Reduction Technology as Reported to the National Healthcare Safety Network Hemovigilance Module. Transfus Med Rev. 2021 04; 35(2):78-84.
Score: 0.181
-
Wiersum-Osselton JC, Whitaker B, Grey S, Land K, Perez G, Rajbhandary S, Andrzejewski C, Bolton-Maggs P, Lucero H, Renaudier P, Robillard P, Santos M, Schipperus M. Revised international surveillance case definition of transfusion-associated circulatory overload: a classification agreement validation study. Lancet Haematol. 2019 Jul; 6(7):e350-e358.
Score: 0.040